  Succinylcholine -Up Regulation of Nicotinic Acetylcholine Receptors (nAChRs) section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; }

### Succinylcholine (SCh) -Up Regulation of Nicotinic Acetylcholine Receptors (nAChRs)

"Up-regulation" refers to the dramatic increase in the number of nAChRs, with many new nAChRs spreading across the entire muscle cell membrane.

Increase in serum potassium from SCh:

With the administration of SCh, the prolonged depolarization of nACnRs

causes a subsequent release of potassium into the bloodstream.

In healthy individuals, the average increase in serum potassium is 0.5 mEq/dL

This is a normal, mild, and transient.

POST-junctional nAChRs vs EXTRA-junctional nAChRs:

Besides post-junctional nAChRs, there are always some extra-junctional nAChRs in small numbers that are not accounted for.

When an injury or disease causes muscle inactivity or denervation, the number of extra-junctional nAChRs increases dramatically and rapidly proliferates across the entire muscle.

These extra-junctional receptors are immature and do not desensitize normally.

The proliferation of these abnormal nAChRs across the muscle membrane may result in a

life-threatening hyperkalemia from the efflux of potassium after the administration of SCh.

**Conditions with up-regulations of nAChRs:** Avoid SCh

Also refer to _"Succinylcholine Contraindications Cheat Sheets"_

ALS

Post-24-hour burn patients

Gullain-Barré Syndrome

Critically ill or immobilized for > 3 days

Crush injury-Muscle trauma

When anesthesia providers are requested to intubate a patient in the ICU:

Avoid administering SCh if the patient has been immobile for > 3 days.

Succinylcholine-induced Hyperkalemia and Beyond

Anesthesiology 2009; 111:1372–7

Gerald A. Gronert, M.D

Cardiac Arrest after Succinylcholine: Mortality Greater with Rhabdomyolysis Than Receptor Upregulation

"Anesthesiology 3, 2001, Vol.94, 523-529.

Gerald A. Gronert, M.D.

Pathophysiology of hyperkalemia induced by succinylcholine

Anesthesiology, 1975 Jul;43(1):89-99.

G A Gronert, R A Theye